TY - JOUR
T1 - CpG methylation in the Fhit regulatory region
T2 - Relation to Fhit expression in murine tumors
AU - Han, Shuang Yin
AU - Iliopoulos, Dimitrios
AU - Druck, Teresa
AU - Guler, Gulnur
AU - Grubbs, Clinton J.
AU - Pereira, Michael
AU - Zhang, Zhongqiu
AU - You, Ming
AU - Lubet, Ronald A.
AU - Fong, Louise Y.Y.
AU - Huebner, Kay
N1 - Funding Information:
This research was supported by National Cancer Institute Contract N01-CN-15128, N01-CN-15113, N01-CN-25007, a subaward from Ohio Medical College, as well as grants CA77738 and CA56036 from the National Cancer Institute. Gulnur Guler was supported by funding from the University of Hacettepe and from the National Institutes of Health.
PY - 2004/5/13
Y1 - 2004/5/13
N2 - To determine if: (1) 5′ CpG island methylation is related to Fhit inactivation; (2) there are tumor or carcinogen-specific methylation patterns, we examined 35 CpG sites in the promoter, exon and intron 1 of the mouse Fhit gene. In primary tumors of long, urinary bladder and tongue, induced by different carcinogens, 15-35% of sites were methylated, with specific methylation patterns associated with each cancer type, suggesting cancer- or tissue-specific methylation patterns. The methylation patterns were associated with reduced Fhit expression, as determined by immunohistochemical analyses. Methylation of rat Fhit 5′ CpGs in mammary adenocarcinomas, detected by methylation specific PCR amplification, also correlated with reduced gene expression. Thus, there was an overall association between promoter/exon 1 methylation and decreased Fhit expression. In contrast, in cancer-derived cell lines 70-95% of the CpG sites were methylated. This is the first detailed study of the relationship between Fhit 5′ CpG island methylation and Fhit expression in murine tumors, our main models for preclinical cancer studies, and provides evidence that loss of Fhit expression and methylation are correlated in these mouse models and these models will be useful to examine the complex relationships among gene expression, methylation patterns and organ specificity.
AB - To determine if: (1) 5′ CpG island methylation is related to Fhit inactivation; (2) there are tumor or carcinogen-specific methylation patterns, we examined 35 CpG sites in the promoter, exon and intron 1 of the mouse Fhit gene. In primary tumors of long, urinary bladder and tongue, induced by different carcinogens, 15-35% of sites were methylated, with specific methylation patterns associated with each cancer type, suggesting cancer- or tissue-specific methylation patterns. The methylation patterns were associated with reduced Fhit expression, as determined by immunohistochemical analyses. Methylation of rat Fhit 5′ CpGs in mammary adenocarcinomas, detected by methylation specific PCR amplification, also correlated with reduced gene expression. Thus, there was an overall association between promoter/exon 1 methylation and decreased Fhit expression. In contrast, in cancer-derived cell lines 70-95% of the CpG sites were methylated. This is the first detailed study of the relationship between Fhit 5′ CpG island methylation and Fhit expression in murine tumors, our main models for preclinical cancer studies, and provides evidence that loss of Fhit expression and methylation are correlated in these mouse models and these models will be useful to examine the complex relationships among gene expression, methylation patterns and organ specificity.
KW - CpG island methylation
KW - Epigenetics
KW - Fhit promoter
KW - Gene inactivation
KW - Homozygous deletion
KW - Tumor suppressor
UR - http://www.scopus.com/inward/record.url?scp=2542571001&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2542571001&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1207526
DO - 10.1038/sj.onc.1207526
M3 - Article
C2 - 15007387
AN - SCOPUS:2542571001
SN - 0950-9232
VL - 23
SP - 3990
EP - 3998
JO - Oncogene
JF - Oncogene
IS - 22
ER -